Abstract
Three boron compounds which have been considered for use in the treatment of glioma patients, by neutron capture irradiation, have been evaluated in terminal individuals. They are 3-amino-4-carboxybenzeneboronic acid, m-boronosuccinanilic acid, and sodium perhydrodecaborate. The latter compound has been shown to be the most promising from the standpoint of low toxicity and has, in fact, been isolated unchanged, from the urine. Low toxicity is seen to be correlated with biological inertness and high chemical stability.
Footnotes
- Received April 20, 1962.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.